HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Chien-Fu Hung Selected Research

Investigational Therapies (Experimental Therapy)

7/2013Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.
8/2011Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
7/2010Carrageenan as an adjuvant to enhance peptide-based vaccine potency.
1/2010Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.
8/2009Treatment with cyclooxygenase-2 inhibitors enables repeated administration of vaccinia virus for control of ovarian cancer.
4/2009Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer.
1/2009Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects.
8/2008Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination.
10/2007Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Chien-Fu Hung Research Topics

Disease

111Neoplasms (Cancer)
03/2015 - 03/2002
19Infection
10/2015 - 01/2003
16Ovarian Neoplasms (Ovarian Cancer)
05/2014 - 01/2007
7Vaccinia
07/2013 - 11/2002
6Communicable Diseases (Infectious Diseases)
09/2012 - 02/2003
2Hepatocellular Carcinoma (Hepatoma)
03/2014 - 01/2011
2Papilloma (Papillomatosis)
02/2014 - 09/2004
2Necrosis
01/2014 - 03/2010
2Melanoma (Melanoma, Malignant)
02/2013 - 02/2012
1Fever (Fevers)
09/2015
1Inflammation
01/2015
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2015
1Pancreatitis
01/2015
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2015
1Multiple Myeloma
01/2015
1Basal Cell Carcinoma (Rodent Ulcer)
11/2014
1Condylomata Acuminata (Genital Wart)
11/2014
1Merkel Cell Carcinoma
01/2013
1Skin Neoplasms (Skin Cancer)
01/2013
1Colonic Neoplasms (Colon Cancer)
01/2013
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2012
1Fistula
07/2011

Drug/Important Bio-Agent (IBA)

60AntigensIBA
01/2015 - 03/2002
49DNA (Deoxyribonucleic Acid)IBA
03/2015 - 03/2002
27DNA VaccinesIBA
01/2015 - 11/2002
14VaccinesIBA
07/2013 - 01/2003
13A-Form DNA (A-DNA)IBA
01/2014 - 05/2003
11Proteins (Proteins, Gene)IBA
01/2014 - 01/2003
10CalreticulinIBA
01/2015 - 08/2004
8Cisplatin (Platino)FDA LinkGeneric
10/2014 - 05/2008
7Papillomavirus Vaccines (HPV Vaccines)IBA
02/2014 - 01/2007
5LuciferasesIBA
01/2012 - 07/2007
4Paclitaxel (Taxol)FDA LinkGeneric
07/2014 - 01/2013
4megakaryocyte potentiating factorIBA
03/2013 - 01/2007
4Oncogene Proteins (Oncogene Protein)IBA
04/2010 - 07/2006
3bortezomib (Velcade)FDA Link
01/2015 - 08/2008
3Neutralizing AntibodiesIBA
01/2015 - 01/2007
3Proteasome Endopeptidase Complex (Proteasome)IBA
01/2015 - 08/2008
3Neoplasm Antigens (Tumor Antigens)IBA
01/2015 - 07/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2014 - 01/2010
3Carbon MonoxideIBA
10/2013 - 01/2003
3Tumor Viral Antigens (Large T Antigen)IBA
01/2013 - 10/2008
3Interleukin-2 (IL2)IBA
09/2012 - 12/2007
3Poly I-CIBA
08/2011 - 07/2004
3OvalbuminIBA
01/2011 - 07/2009
3HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2009 - 10/2007
3Small Interfering RNA (siRNA)IBA
08/2008 - 01/2005
2imiquimod (Aldara)FDA LinkGeneric
11/2014 - 01/2010
2Toll-Like Receptors (Toll-Like Receptor)IBA
11/2014 - 04/2009
2PlatinumIBA
05/2014 - 01/2013
2N-formylmethionylphenylalanine (FMP)IBA
03/2014 - 01/2011
2Fluorouracil (Carac)FDA LinkGeneric
03/2014 - 01/2011
2Mitoxantrone (Novantrone)FDA LinkGeneric
03/2014 - 01/2011
2LigandsIBA
01/2012 - 04/2009
25,6-dimethylxanthenoneacetic acidIBA
07/2011 - 01/2011
2MucinsIBA
07/2011 - 01/2008
2AntibodiesIBA
11/2008 - 08/2008
2herpes simplex virus type 1 protein VP22IBA
07/2004 - 03/2002
1Silicon Dioxide (Sand)FDA LinkGeneric
09/2015
1GoldIBA
09/2015
1Lipoproteins (Lipoprotein)IBA
01/2015
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2015
1Toll-Like Receptor 7IBA
11/2014
1Poloxamer (Poloxamer 407)IBA
07/2014
1PolymersIBA
07/2014
1polylactic acid-polyglycolic acid copolymer (PLGA)IBA
07/2014
1taxaneIBA
05/2014
1Excipients (Suspending Agents)IBA
04/2014
1Ethyl Ether (Ether)IBA
04/2014
1TocopherolsFDA Link
01/2014
1AutoantigensIBA
01/2014
1Vitamin EFDA LinkGeneric
01/2014
1CD40 Ligand (CD40L)IBA
01/2014
1Histone Deacetylase InhibitorsIBA
10/2013
1Single-Chain AntibodiesIBA
03/2013
1Immunoglobulin G (IgG)IBA
02/2013
1InterleukinsIBA
01/2013
1Carboplatin (JM8)FDA LinkGeneric
01/2013
1Chaperonin 60IBA
09/2012
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2012
1OxidoreductasesIBA
09/2012
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
09/2012
1Monophenol Monooxygenase (Tyrosinase)IBA
01/2012
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2012
1Thymidine KinaseIBA
01/2012
1Toll-Like Receptor 3IBA
08/2011
1Nucleic AcidsIBA
08/2011
1PolyethyleneimineIBA
08/2011
1Human papillomavirus type 16 oncogene protein E7IBA
07/2011
1CytokinesIBA
07/2011

Therapy/Procedure

41Immunotherapy
10/2015 - 03/2002
15Drug Therapy (Chemotherapy)
10/2014 - 01/2007
9Investigational Therapies (Experimental Therapy)
07/2013 - 10/2007
4Radiotherapy
10/2014 - 05/2009
2Lasers (Laser)
09/2015 - 01/2009
2Combination Drug Therapy (Combination Chemotherapy)
03/2014 - 01/2011
2Intraperitoneal Injections
01/2012 - 07/2007
1Intravaginal Administration
03/2015
1Microspheres (Microsphere)
04/2014
1Transplants (Transplant)
01/2014